The SIDER database of drugs and side effects
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Unwanted side effects of drugs are a burden on patients and a severe impediment in the development of new drugs. At the same time, adverse drug reactions (ADRs) recorded during clinical trials are an important source of human phenotypic data. It is therefore essential to combine data on drugs, targets and side effects into a more complete picture of the therapeutic mechanism of actions of drugs and the ways in which they cause adverse reactions. To this end, we have created the SIDER ('Side Effect Resource', http://sideeffects.embl.de) database of drugs and ADRs. The current release, SIDER 4, contains data on 1430 drugs, 5880 ADRs and 140 064 drug-ADR pairs, which is an increase of 40% compared to the previous version. For more fine-grained analyses, we extracted the frequency with which side effects occur from the package inserts. This information is available for 39% of drug-ADR pairs, 19% of which can be compared to the frequency under placebo treatment. SIDER furthermore contains a data set of drug indications, extracted from the package inserts using Natural Language Processing. These drug indications are used to reduce the rate of false positives by identifying medical terms that do not correspond to ADRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, as SIDER was most recently updated in 2015, no currently up-to-date, computable databases exist for on-label ADEs.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“One of the most widely utilized ADE databases derived from drug label data is SIDER, constructed using a dictionary-based named entity recognition (NER) method to extract adverse event terms from FDA Structured Product Labeling (SPLs) drug labels13.”
From OnSIDES database: Extracting adverse drug events from drug labels using natural language processing models (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRING v9.1: protein-protein interaction networks, with increased coverage and integration
Franceschini, A., Szklarczyk, D., Frankild, S., Kuhn, M., Simonovic, M., Roth, A., Lin, J., Minguez, P., Bork, P., von Mering, C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1094 · Cited by 4,398
Self-citationDrug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248 · cited 1×
“For example, it was shown that ADRs can be used to predict drug targets (1) and that causal relations between targets and ADRs can be elucidated (2,3).”
BackgroundSelf-citationThe Stanford typed dependencies representation
de Marneffe, M.-C., & Manning, C. D. (2008) · Coling 2008: Proceedings of the workshop on Cross-Framework and Cross-Domain Parser Evaluation - CrossParser '08 · doi:10.3115/1608858.1608859 · Cited by 918
A side effect resource to capture phenotypic effects of drugs
Kuhn, M., Campillos, M., Letunic, I., Jensen, L. J., & Bork, P. (2010) · Molecular Systems Biology · doi:10.1038/msb.2009.98 · Cited by 899
Self-citationPREDICT: a method for inferring novel drug indications with application to personalized medicine
Gottlieb, A., Stein, G. Y., Ruppin, E., & Sharan, R. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.26 · Cited by 881
STITCH 4: integration of protein–chemical interactions with user data
Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., von Mering, C., Jensen, L. J., & Bork, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1207 · Cited by 487
Self-citationExtraction of potential adverse drug events from medical case reports
Gurulingappa, H., Mateen‐Rajpu, A., & Toldo, L. (2012) · Journal of Biomedical Semantics · doi:10.1186/2041-1480-3-15 · Cited by 211
The SPECIES and ORGANISMS Resources for Fast and Accurate Identification of Taxonomic Names in Text
Pafilis, E., Frankild, S. P., Fanini, L., Faulwetter, S., Pavloudi, C., Vasileiadou, A., Arvanitidis, C., & Jensen, L. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065390 · Cited by 206
Self-citationCai, M., Xu, Q., Pan, Y.-J., Pan, W., Ji, N., Li, Y.-B., Jin, H.-J., Liu, K., & Ji, Z. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1066 · Cited by 131
Systematic identification of proteins that elicit drug side effects
Kuhn, M., Al Banchaabouchi, M., Campillos, M., Jensen, L. J., Gross, C., Gavin, A., & Bork, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.10 · Cited by 120
Self-citation
Cited by
Items 601–700 of 1,001
Zhuang, L., Wang, H., Zhao, J. M., & Sun, Y. (2023) · Information Sciences · doi:10.1016/j.ins.2023.119139 · Cited by 16
Ivanov, S. M., Lagunin, A. A., Filimonov, D. A., & Poroikov, V. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006851 · Cited by 16
Authenticity and credibility aware detection of adverse drug events from social media
Hoang, T., Liu, J., Pratt, N. L., Zheng, V. W., Chang, K. C., Roughead, E. E., & Li, J. (2018) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2018.10.003 · Cited by 16
Jain, S., & Ecker, G. F. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_26 · Cited by 16
Pétervári, M., Benczik, B., Balogh, O. M., Petrovich, B., Ágg, B., & Ferdinandy, P. (2022) · Drug Safety · doi:10.1007/s40264-022-01225-9 · Cited by 16
Clinical side-effects based drug repositioning for anti-epileptic activity
Kumar, P., Sheokand, D., Grewal, A., Saini, V., & Kumar, A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2199874 · Cited by 16
M2GCN: multi-modal graph convolutional network for modeling polypharmacy side effects
Liu, Q., Yao, E., Liu, C., Zhou, X., Li, Y., & Xu, M. (2022) · Applied Intelligence · doi:10.1007/s10489-022-03839-z · Cited by 16
UniMatch: Universal Matching from Atom to Task for Few-Shot Drug Discovery
Li, R., Li, M., Liu, W., Zhou, Y., Zhou, X., Yao, Y., Zhang, Q., & Chen, H. (2025) · International Conference on Learning Representations · doi:10.48550/arxiv.2502.12453 · Cited by 16
Prediction of drug side effects with transductive matrix co-completion
Liang, X., Fu, Y., Qu, L., Zhang, P., & Chen, Y. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad006 · Cited by 16
Examining drug and side effect relation using author–entity pair bipartite networks
Jeong, Y. K., Xie, Q. S., Yan, E., & Song, M. (2019) · Journal of Informetrics · doi:10.1016/j.joi.2019.100999 · Cited by 16
Jiang, Y., Mason, M., Cho, Y., Chittiprolu, A., Zhang, X., Harden, K. L., Gong, Y., Harris, M. R., & Barton, D. L. (2022) · BMC Cancer · doi:10.1186/s12885-022-10026-3 · Cited by 16
Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data
Zhan, C., Roughead, E. E., Liu, L., Pratt, N. L., & Li, J. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103603 · Cited by 16
Ghorbanali, Z., Zare‐Mirakabad, F., Salehi, N., Akbari, M., & Masoudi‐Nejad, A. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05479-7 · Cited by 16
Bi-level Contrastive Learning for Knowledge-Enhanced Molecule Representations
Jiang, P., Xiao, C., Fu, T., Bhatia, P., Kass‐Hout, T., Sun, J., & Han, J. (2025) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v39i1.32013 · Cited by 16
Predicting drug–disease associations by network embedding and biomedical data integration
Wei, X., Zhang, Y., Huang, Y.-N., & Fang, Y. (2019) · Data Technologies and Applications · doi:10.1108/dta-01-2019-0004 · Cited by 16
Anti-Drug Response and Drug Side Effect Prediction Methods: A Review
Singh, D. P., Gupta, A., & Kaushik, B. (2022) · Lecture notes on data engineering and communications technologies · doi:10.1007/978-981-19-3391-2_11 · Cited by 16
Leveraging pleiotropy for the improved treatment of psychiatric disorders
Woodward, D. J., Thorp, J. G., Middeldorp, C. M., Akóṣílè, W., Derks, E. M., & Gerring, Z. F. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02771-7 · Cited by 15
Manen-Freixa, L., & Antolín, A. A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2376643 · Cited by 15
Predicting therapeutic and side effects from drug binding affinities to human proteome structures
Sawada, R., Sakajiri, Y., Shibata, T., & Yamanishi, Y. (2024) · iScience · doi:10.1016/j.isci.2024.110032 · Cited by 15
Development of an adverse drug event network to predict drug toxicity
Wu, Q., Taboureau, O., & Audouze, K. (2020) · Current Research in Toxicology · doi:10.1016/j.crtox.2020.06.001 · Cited by 15
A review of feature selection strategies utilizing graph data structures and Knowledge Graphs
Shao, S., Ribeiro, P. H., Ramirez, C. M., & Moore, J. H. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae521 · Cited by 15
Zhao, K., & So, H. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1706.03014 · Cited by 15
Jensen, L. J. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/067132 · Cited by 15
Self-citationYan, Y., Yang, Y., Tong, Z., Wang, Y., Yang, F., Pan, Z., Liu, C., Bai, M., Xie, Y., Li, Y., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101275 · Cited by 15
Network-based analysis of transcriptional profiles from chemical perturbations experiments
Mulas, F., Li, A., Sherr, D. H., & Monti, S. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1536-9 · Cited by 15
Park, S., Lee, S., Pak, M., & Kim, S. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3350083 · Cited by 15
Qian, Y., Wang, Y., Liu, J., Zou, Q., Ding, Y., Guo, X., & Ding, W. (2024) · Information Fusion · doi:10.1016/j.inffus.2024.102894 · Cited by 15
Application of in Silico Technologies for Drug Target Discovery and Pharmacokinetic Analysis
Iwata, H. (2023) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c22-00638 · Cited by 15
A multimodal vision knowledge graph of cardiovascular disease
Rjoob, K. W. Y., McGurk, K. A., Zheng, S. L., Curran, L., Ibrahim, M., Zeng, L., Kim, V., Tahasildar, S., Kalaie, S., Senevirathne, D. S., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00757-4 · Cited by 15
Sharma, V., Gelin, L. F. F., & Sarkar, I. N. (2020) · Bioinformatics and Biology Insights · doi:10.1177/1177932220921350 · Cited by 15
Drug Side Effect Prediction with Deep Learning Molecular Embedding in a Graph-of-Graphs Domain
Pancino, N., Perron, Y., Bongini, P., & Scarselli, F. (2022) · Mathematics · doi:10.3390/math10234550 · Cited by 15
Adverse drug event detection using reason assignments in FDA drug labels
Sutphin, C., Lee, K., Yepes, A. J., Uzuner, Ö., & McInnes, B. T. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103552 · Cited by 15
Alshahrani, M., Almansour, A., Alkhaldi, A., Thafar, M. A., Uludağ, M., Essack, M., & Hoehndorf, R. (2022) · PeerJ · doi:10.7717/peerj.13061 · Cited by 15
Zhang, L., Niu, D., Zhang, B., Zhang, Q., & Li, Z. (2024) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2024.3381896 · Cited by 15
Primum non nocere: In silico prediction of adverse drug reactions of antidepressant drugs
Güneş, S. S., Yeşil, Ç., Gürdal, E. E., Korkmaz, E. E., Yarım, M., Aydın, A., & Sipahi, H. (2021) · Computational Toxicology · doi:10.1016/j.comtox.2021.100165 · Cited by 15
An automatic approach for constructing a knowledge base of symptoms in Chinese
Ruan, T., Wang, M., Sun, J., Wang, T., Zeng, L., Yin, Y., & Gao, J. (2016) · IEEE International Conference on Bioinformatics and Biomedicine (BIBM) · doi:10.1109/bibm.2016.7822767 · Cited by 15
Predicting drug-drug adverse reactions via multi-view graph contrastive representation model
Zhuang, L., Wang, H., Hua, M., Li, W., & Zhang, H. (2023) · Applied Intelligence · doi:10.1007/s10489-022-04372-9 · Cited by 15
A data-driven method to detect adverse drug events from prescription data
Zhan, C., Roughead, E. E., Liu, L., Pratt, N. L., & Li, J. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.07.013 · Cited by 15
Fusaroli, M., Simonsen, A., Borrie, S. A., Low, D. M., Parola, A., Raschi, E., Poluzzi, E., & Fusaroli, R. (2023) · Journal of Speech Language and Hearing Research · doi:10.1044/2023_jslhr-22-00739 · Cited by 14
CART—a chemical annotation retrieval toolkit
Deghou, S., Zeller, G., Iskar, M., Driessen, M., Castillo, M., van Noort, V., & Bork, P. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw233 · Cited by 14
Self-citationCPMKG: a condition-based knowledge graph for precision medicine
Yang, J., Zhuang, X., Li, Z., Xiong, G., Xu, P., Ling, Y., & Zhang, G. (2024) · Database · doi:10.1093/database/baae102 · Cited by 14
Ebadi, A., Kaur, M., & Liu, Q. (2025) · Computational Materials Science · doi:10.1016/j.commatsci.2025.113904 · Cited by 14
Machine learning approaches for predicting the onset time of the adverse drug events in oncology
Timilsina, M., Tandan, M., & Nováček, V. (2022) · Machine Learning with Applications · doi:10.1016/j.mlwa.2022.100367 · Cited by 14
Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity
Uddin, M. E., Moseley, A., Hu, S., & Sparreboom, A. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13635 · Cited by 14
PIMD: An Integrative Approach for Drug Repositioning using Multiple Characterization Fusion
He, S., Wen, Y., Yang, X., Liu, Z., Song, X., Huang, X., & Bo, X. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2018.10.012 · Cited by 14
Accurate classification of materials with elEmBERT: Element embeddings for chemical benchmarks
Shermukhamedov, S. A., Mamurjonova, D., & Probst, M. M. (2025) · APL Machine Learning · doi:10.1063/5.0232529 · Cited by 14
Shkil, D. O., Muhamedzhanova, A. A., Petrov, P. I., Скорб, Е. В., Aliev, T. A., Steshin, I., Tumanov, A. V., Kislinskiy, A. S., & Fedorov, M. V. (2024) · Molecules · doi:10.3390/molecules29081826 · Cited by 14
Chen, Y.-H., Shih, Y.-T., Chien, C. ‐., & Tsai, C.-S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266435 · Cited by 14
Explainable Drug Repurposing Approach From Biased Random Walks
Castiglione, F., Nardini, C., Onofri, E., Pedicini, M., & Tieri, P. (2022) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2022.3191392 · Cited by 14
Lund, L. C., Jensen, P. H., Pottegård, A., Andersen, M. T., Pratt, N. L., & Hallas, J. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14982 · Cited by 14
Jala, A., Ponneganti, S., Vishnubhatla, D. S., Bhuvanam, G., Mekala, P. R., Varghese, B., Radhakrishnanand, P., Adela, R., Murty, U. S., & Borkar, R. M. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1928687 · Cited by 14
Kim, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20192-1 · Cited by 14
Li, Y., Yang, Y., Tong, Z., Wang, Y., Mi, Q., Bai, M., Liang, G., Li, B., & Shu, K. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae172 · Cited by 14
Detecting signals of detrimental prescribing cascades from social media
Hoang, T., Liu, J., Pratt, N. L., Zheng, V. W., Chang, K. C., Roughead, E. E., & Li, J. (2016) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2016.06.002 · Cited by 14
ADENet: a novel network-based inference method for prediction of drug adverse events
Yu, Z., Wu, Z., Li, W., Liu, G., & Tang, Y. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab580 · Cited by 14
Knowledge-enhanced Relation Graph and Task Sampling for few-shot molecular property prediction
Wang, Z., Jiang, T., Lu, Y., Bao, X., Yu, S., Wei, B., Xuan, Q., & Wang, H. (2025) · Information Sciences · doi:10.1016/j.ins.2025.122357 · Cited by 14
Qiu, X., Shao, S., Wang, H., & Tan, X. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108524 · Cited by 14
Learning from biomedical linked data to suggest valid pharmacogenes
Dalleau, K., Marzougui, Y., da Silva, S., Ringot, P., Ndiaye, N. C., & Coulet, A. (2017) · Journal of Biomedical Semantics · doi:10.1186/s13326-017-0125-1 · Cited by 14
SympGAN: A systematic knowledge integration system for symptom–gene associations network
Lu, K., Yang, K., Sun, H., Zhang, Q., Zheng, Q., Xu, K., Chen, J., & Zhou, X. (2023) · Knowledge-Based Systems · doi:10.1016/j.knosys.2023.110752 · Cited by 14
Integrated ML-Based Strategy Identifies Drug Repurposing for Idiopathic Pulmonary Fibrosis
Ahmed, F., Samantasinghar, A., Bae, M. A., & Choi, K. H. (2024) · ACS Omega · doi:10.1021/acsomega.4c03796 · Cited by 13
Advancements in Rational Multi‐Targeted Drug Discovery
Ravikumar, B., Cichońska, A., Sahni, N., Aittokallio, T. A., & Rahman, R. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch9 · Cited by 13
Pisces: A multi-modal data augmentation approach for drug combination synergy prediction
Xu, H., Lin, J., Woicik, A., Liu, Z., Ma, J., Zhang, S., Poon, H., Wang, L., & Wang, S. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100892 · Cited by 13
Chignon, A., Mathieu, S., Rufiange, A., Argaud, D., Voisine, P., Bossé, Y., Arsenault, B. J., Thériault, S., & Mathieu, P. (2022) · Human Genomics · doi:10.1186/s40246-022-00381-4 · Cited by 13
Overview of Drug Polypharmacology and Multitargeted Molecular Design
Chaudhari, R., Tan, Z., & Zhang, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12323-6 · Cited by 13
Xu, W.-M., Yang, K., Jiang, L., Hu, J., & Zhou, X. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00007 · Cited by 13
Binkheder, S., Wu, H., Quinney, S. K., Zhang, S., Zitu, M. M., Chiang, C., Wang, L., Jones, J., & Li, L. (2022) · Journal of Biomedical Semantics · doi:10.1186/s13326-022-00272-6 · Cited by 13
Wunnava, S., Qin, X., Kakar, T., Socrates, V., Wallace, A., & Rundensteiner, E. A. (2017) · ACM Symposium on Applied Computing · doi:10.1145/3019612.3022875 · Cited by 13
Roberts-Nuttall, J., Jones, A. M., Castellani, M., & Pham, D. T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340900 · Cited by 13
Learning important features from multi-view data to predict drug side effects
Liang, X., Zhang, P., Li, J., Fu, Y., Qu, L., Chen, Y., & Chen, Z. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0402-3 · Cited by 13
Improving drug repositioning with negative data labeling using large language models
Picard, M., Leclercq, M., Bodein, A., Scott‐Boyer, M., Périn, O., & Droit, A. (2025) · Journal of Cheminformatics · doi:10.1186/s13321-025-00962-0 · Cited by 13
A Deep Learning Approach to the Prediction of Drug Side–Effects on Molecular Graphs
Bongini, P., Messori, E., Pancino, N., & Bianchini, M. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3311015 · Cited by 13
The support of genetic evidence for cardiovascular risk induced by antineoplastic drugs
Cui, H. S., Zuo, S., Liu, Z., Liu, H., Wang, J., You, T., Zheng, Z., Zhou, Y., Qian, X., Yao, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb8543 · Cited by 13
Leveraging digital media data for pharmacovigilance.
Farooq, H., Niaz, J. S., Fakhar, S., & Naveed, H. (2020) · PubMed Central · Cited by 13
Deng, Z., Tu, W., Deng, Z., & Hu, Q. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00175 · Cited by 13
Drug voyager: a computational platform for exploring unintended drug action
Oh, M., Ahn, J., Lee, T., Jang, G., Park, C., & Yoon, Y. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1558-3 · Cited by 13
Pelletier, A. R., Ramirez, J., Adam, I., Sankar, B. S., Steinecke, D., Bui, A. A. T., Wang, W. W., & Ping, P. (2025) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2025.100436 · Cited by 13
Dholakia, D., Kalra, A., Misir, B. R., Kanga, U., & Mukerji, M. (2022) · BMC Genomics · doi:10.1186/s12864-021-08239-0 · Cited by 13
Advancing Molecular Graph-Text Pre-training via Fine-grained Alignment
Li, Y., Fang, Y., Zhang, M., & Shi, C. (2025) · ACM SIGKDD Conference on Knowledge Discovery and Data Mining (KDD) · doi:10.1145/3711896.3736834 · Cited by 13
Predicting Renal Toxicity of Compounds with Deep Learning and Machine Learning Methods
Mazumdar, B., Sarma, P. K. D., & Mahanta, H. J. (2023) · SN Computer Science · doi:10.1007/s42979-023-02258-2 · Cited by 13
Liu, Y., Shi, J., & Chen, Y. (2017) · Journal of the Association for Information Science and Technology · doi:10.1002/asi.23929 · Cited by 13
A study on improving drug–drug interactions prediction using convolutional neural networks
Kumari, D., Agrawal, D., Nema, A., Raj, N., Panda, S., Christopher, J. J., Singh, J. K., & Behera, S. (2024) · Applied Soft Computing · doi:10.1016/j.asoc.2024.112242 · Cited by 12
In Silico Systems Pharmacology to Assess Drug's Therapeutic and Toxic Effects
Aguayo‐Orozco, A., Audouze, K., Brunak, S., & Taboureau, O. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160907093215 · Cited by 12
A context-augmented large language model for accurate precision oncology medicine recommendations
Jun, H., Tanaka, Y., Johri, S., Camp, S. Y., Bao, E. L., Carvalho, F. L. F., Gui, D. Y., Jordan, A. C., Labaki, C., Martin, S. D., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2025.12.017 · Cited by 13
Cristiano, G., Aguirre‐Plans, J., Oliva, B., & Fernández‐Fuentes, N. (2022) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2022.906644 · Cited by 12
Stimulus switches for spatial-temporal precision in therapeutic delivery systems
Zhang, F., Li, J., Gao, Y., Wei, Y., Wen, D., & Wang, Z. (2024) · Nano Research · doi:10.26599/nr.2025.94907571 · Cited by 12
Investigating Side Effect Modules in the Interactome and Their Use in Drug Adverse Effect Discovery
Güney, E. (2017) · Springer proceedings in complexity · doi:10.1007/978-3-319-54241-6_21 · Cited by 12
Drug Mechanism: A bioinformatic update
Cirinciani, M., Pozzo, E. D., Trincavelli, M. L., Milazzo, P., & Martini, C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116078 · Cited by 12
Asadi‐Pooya, A. A., Malekpour, M., Zamiri, B., Kashkooli, M., & Firouzabadi, N. (2023) · Epilepsia Open · doi:10.1002/epi4.12749 · Cited by 12
The future of metronomic chemotherapy: experimental and computational approaches of drug repurposing
Abdelrady, Y. A., Thabet, H., & Sayed, A. M. M. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00662-w · Cited by 12
A comprehensive review of the data and knowledge graphs approaches in bioinformatics
Galluzzo, Y. (2024) · Computer Science and Information Systems · doi:10.2298/csis230530027g · Cited by 12
Wang, Z., Sun, L., Xu, Y., Huang, J., Yang, F., & Chang, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05893-2 · Cited by 12
Xu, Q., Dai, X., Luo, L., Lin, M., Xu, Y., Zhao, Y., Huang, D., Qiu, H., Liang, L., Liu, H., et al. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00473 · Cited by 12
Mangione, W., Falls, Z., & Samudrala, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1113007 · Cited by 12
Lu, Y.-C., Tseng, L.-W., Huang, Y.-C., Yang, C.-W., Chen, Y., & Chen, H. (2022) · Pharmaceuticals · doi:10.3390/ph15070794 · Cited by 12
Wen, Q., Liu, R., & Zhang, P. (2021) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-021-01617-4 · Cited by 12
Ren, Z.-H., Yu, C.-Q., Li, L., You, Z., Pan, J., Guan, Y.-J., & Guo, L.-X. (2022) · Biology · doi:10.3390/biology11050758 · Cited by 12
Balasundaram, P., Veerappapillai, S., & Ramanathan, K. (2016) · BioDrugs · doi:10.1007/s40259-016-0200-7 · Cited by 12
Bories, M., Bouzillé, G., Cuggia, M., & Corre, P. L. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071410 · Cited by 12
Lee, S., Song, G.-E., Seok, J., Kim, J., Kim, M. W., Rhee, J., Park, S., Jeong, K. S., Lee, S., Lee, Y. H., et al. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116108 · Cited by 12
Xiao-jie, H., Xie, X., Huang, S., Wu, S., & Huang, L. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1431941 · Cited by 12
Metadata
- Authors
- Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P.
- Affiliations
- Max Planck Institute of Molecular Cell Biology and Genetics (DE)
- University of Copenhagen (DK)
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-10-19
- Volume
- 44
- Issue
- D1
- Pages
- D1075-D1079
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC4702794
- OpenAlex
- W2145578524
- Cited by
- 1,451
- References
- 18
- Citations by year
- 2026: 123 · 2025: 199 · 2024: 194 · 2023: 160 · 2022: 156 · 2021: 183 · 2020: 131 · 2019: 111 · 2018: 82 · 2017: 74 · 2016: 37
- FWCI
- 51.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- European Molecular Biology Laboratory
- Novo Nordisk (NNF14CC0001)
- Novo Nordisk Fonden (NNF 14CC0001)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- SIDER, adverse drug reactions, drug safety, drug indications, package inserts, natural language processing, therapeutic target
- MeSH terms
- Drug Labeling, Internet, Databases, Pharmaceutical, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.